Celgene Therapy Areas

Our research ethos centres on driving clinical advances in rare diseases and in therapeutic areas where medical need is greatest. Traditionally, we have focused on underserved and difficult-to-treat haematological conditions, especially multiple myeloma and myelodysplastic syndromes.

Alongside research into rare haematological conditions, we are now building on our foundations to provide new treatments options in oncology and inflammatory conditions.



UK-CELG150025z
Date of preparation: May 2015